Recursion
762 employees
Biotech/Pharma
Public · $452.0M
Open positions (21)
Company details
Team Size762
IndustryBiotech/Pharma
Funding
Total raised
$452.0M
Last stage
Public
Investors
Baillie Gifford
Total raised
$452.0M
Last stage
Public
Investors
Dean Li
Co-founder of Recursion from his lab at the University of Utah. Current President of Merck Research Labs. Previously VP of Translational Medicine at Merck. Served as H.A. & Edna Benning Professor of Medicine and Cardiology and vice-dean of research at University of Utah Health Science Center.
Chris Gibson
Developed the technology and approach that seeded Recursion during his MD/PhD work at the University of Utah. Left medical school to build Recursion. Graduate of Rice University with degrees in bioengineering and management. Previously served as CEO.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.